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Density functional theoryClassical atom-scale molecular dynamics simulations, constrained free energy calculations, and quantumme-
chanical (QM) calculations are employed to study the diffusive translocation of ciproﬂoxacin (CPFX) across
lipid membranes. CPFX is considered here as a representative of the ﬂuoroquinolone antibiotics class. Neutral
and zwitterionic CPFX coexist at physiological pH, with the latter being predominant. Simulations reveal that
only the neutral form permeates the bilayer, and it does so through a novel mechanism that involves disso-
lution of concerted stacks of zwitterionic ciproﬂoxacins. Subsequent QM analysis of the observed molecular
stacking shows the important role of partial charge neutralization in the stacks, highlighting how the zwitter-
ionic form of the drug is neutralized for translocation. The ﬁndings propose a translocation mechanism in
which zwitterionic CPFX molecules approach the membrane in stacks, but they diffuse through the mem-
brane as neutral CPFX monomers due to intermolecular transfer of protons favored by partial solvation
loss. The mechanism is expected to be of importance in the permeation and translocation of a variety of
ampholitic drugs with stacking tendencies.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Fluoroquinolones (FQs) developed by modiﬁcations of an old
antibacterial agent (nalidixic acid) have since the mid-1980s dra-
matically changed the antibiotic market. Their discovery has gener-
ated considerable clinical and scientiﬁc interest due to their broad
antibacterial spectrum with less resistance, rapid bactericidal effect,
and good oral absorption properties. As such, ciproﬂoxacin (CPFX,
see Fig. 1), which belongs to the second generation of FQs, is one of
the most widely used antibiotics for the treatment of respiratory,
urinary, and enteric infections. Very importantly, similarly to other
clinically antibacterial drugs, FQs have intracellular target sites.
Therefore as a ﬁrst hypothesis their broad spectrum of action is
due to their ability to cross bacterial envelopes and cytoplasmic
membranes [1], and consequently the antibacterial activity of FQs
appears to result from the combination of efﬁcient cellular mem-
brane penetration and DNA gyrase inhibiting activity. The centralcin; MD, molecular dynamics;
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).
rights reserved.issue at the moment is that the molecular-scale entry mechanism
of these drugs through membranes is still under debate, see below.
Membrane proteins play an important role in the uptake of FQs by
Gram-negative bacteria through their outer membrane [2,3]. Mean-
while, translocation through the inner membrane takes place via pas-
sive diffusion, both in Gram-negative bacteria and in the membrane
of Gram-positive organisms [1,4]. Recent parallel artiﬁcial membrane
permeability assay studies have also proven that as much as 80% of
CPFX passively permeates through the membrane, while paracellular
permeability through pores is responsible for the rest 20% [5]. Consid-
ering the passive diffusion of FQs, one has to take into account that they
have two ionization states coexisting at physiological pH: a zwitterionic
(and overall uncharged) form with a signiﬁcant dipole, and an un-
charged neutral form (with negligible/minor dipole; see Fig. 1) [6–9]. De-
spite their predominant zwitterionic character [7–9] FQs are known to
cross membranes via passive transport. This view is also supported by
various membrane vesicle and liposome experiments [10–12], which
suggest that the zwitterionic species is responsible for the diffusion
through the cellular membrane [10].
It is common knowledge that the intrinsic lipophilicity of neutral
species is greater than that of cations and anions. In contrast, much
controversy surrounds the lipophilicity of zwitterions, which is very
low according to some authors but marked according to others [6],
and no direct experimental method is available to determine sepa-
rately their individual partition coefﬁcients. What is more, inter-
Fig. 1.Molecular structures of neutral and zwitterionic CPFX. The central structural unit of CPFX is a quinolone ring with the ﬂuorine atom at C-6, a piperazine moiety at C-7,
a cyclopropyl ring at position 1 and a carboxyl group at position 3.
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static bonds, and folding often increase lipophilicity [6,13], and these
effects could make a difference also for the zwitterionic form of CPFX.
Taken together, the available data suggest that not only the small
fraction of neutral-form FQs translocates through the lipid bilayer. In-
stead, in some unknownmanner diffusion of zwitterionic FQs across a
bilayer does take place, too, to account for the high portion of the
translocated drug. Importantly, to understand the action of FQs in
general, one ﬁrst has to unravel its translocation mechanism.
To this end, we use here atomistic molecular dynamics (MD) sim-
ulations to study the behavior of both neutral and zwitterionic CPFX
in water as well as their translocation across a lipid bilayer composed
of unsaturated phosphatidylcholine (PC) molecules. While many bac-
terial membranes consist of a mixture of phosphatidylethanolamine
(PE) and phosphatidylglycerol (PG) lipids, the PC bilayer considered
here offers a good starting point for our simulations, as it is the
most studied and best understood membrane model overall. Further-
more, we determine the free energy proﬁle of CPFX across the lipid
bilayer and use it to discuss permeation characteristics of the drug. Fi-
nally, these classical simulations are complemented with quantum
mechanical (QM) calculations at density functional theory (DFT)
level to address questions raised by atomistic MD simulations and
to propose a complete picture of the penetration process.2. Computational methods and models
2.1. Molecular dynamics simulations
Atomic-scale MD simulations of neutral and zwitterionic CPFX
molecules were performed both in the presence and in the absence
of 1,2-Dilinoleoyl-sn-Glycero-3-phosphatidylcholine lipid bilayer.
We used a previously equilibrated lipid bilayer [14] consisting of
128 PC molecules, which are phospholipids with di-unsaturated hy-
drocarbon chains, each including 18 carbons with double bonds at
positions 9 and 12 (linoleic acid, 18:2c9,12). Long tails were chosen
as they ensure that the bilayer is in the ﬂuid phase. Fully hydrated bi-
layers with either ~3250 or ~7500water molecules were considered,
resulting in two different thicknesses for the water layer. In the
starting conﬁguration 10 CPFXmolecules were distributed randomly
in the water phase.
We used the all-atomOPLS (optimized parameters for liquid simula-
tions) force ﬁeld [15–18] with partial charges on the PC head group
taken from Takaoka et al. [19]. Details of the force ﬁeld implementation
are given in ref. [14]. It was shown by Rog et al. that this parameteriza-
tion reproduces correctly the properties of lipid bilayers composed of
the given phosphatidylcholines [20]. Partial atomic charges for CPFX
were derived in line with the OPLS methodology by ﬁtting them to
the electrostatic potential using the RESP procedure [21]. First, the
Merz–Kollman molecular electrostatic potential (MEP) was computed
for the optimized molecule structure [22]. The MEP calculations were
performed at Hartree–Fock level by employing the 6–31G* basis set
using the Gaussian 03 program [23]. The charge ﬁtting was done auto-
matically using the RESP ESP charge derived (R.E.D.) software versionIII (a, b, c). Water was described by the TIP3P model, which is compat-
ible with the OPLS parameterization [24].
Simulations in every system were performed using the GROMACS
software package [25,26] over a time scale of 300 ns. The steepest-
descent algorithmwas employed tominimize the energies of the initial
structures prior to actualMD simulations. Periodic boundary conditions
were used in all directions with the minimum image convention. The
LINCS algorithm [27] was employed to constrain covalent bonds, and
the time step was set to 2 fs. The simulations were carried out at con-
stant pressure (1 bar) using semi-isotropic control [28]with a time con-
stant of 2 ps. The bilayer systems were kept in the ﬂuid phase at 310 K
with theweak coupling Berendsen scheme [28] using a time constant of
0.2 ps. The Lennard–Jones interactions were cut off at 1.0 nm, and for
the electrostatic interactions we employed the particle mesh Ewald
method with a real space cutoff of 1.0 nm. The list of non-bonded
pairs was updated every 10th time step. The simulation protocol used
in this study has been successfully applied in many previous MD simu-
lation studies of lipid bilayers [14,20,29–31].
2.2. Free energy proﬁles from z-constraint calculations
In order to obtain detailed information on the energetics of CPFX
partitioning, a set of simulations with constraints was performed for
both the zwitterionic and the neutral forms of CPFX. The center of
mass of CPFX was constrained in z direction (along the membrane nor-
mal direction) at a total of 35 different locations from the membrane
core to the bulk water phase with a spacing of 0.1 nm. The starting con-
ﬁgurations for these windows were obtained by ﬁrst pulling the CPFX
molecule from the water phase to the membrane center with an um-
brella potential, whose reference point was moved at a constant veloc-
ity. The frames with correct distances between themembrane center of
mass and the CPFX molecule were then extracted from the obtained
trajectory.
Each windowwas simulated for 15 ns, and the latter half was used
in the analysis. A rather long equilibration time was employed to en-
sure that the molecule probed its equilibrium orientations within the
membrane. Even though the z coordinate of the CPFX molecule was
constrained in the simulations, the molecule was allowed to diffuse
freely in the xy-plane. The value of the force experienced by CPFX in
z direction was saved every 10 steps. The excess free energy with re-
spect to water at a chosen depth z from the bulk water phase was
obtained through integration of the mean of this force in the direction
of pulling. All free energy proﬁles were calculated for one lipid leaﬂet
and have been symmetrized. Other simulation parameters were kept
at the same values as in the equilibrium MD simulations described in
Section 2.2.
2.3. Quantum mechanical calculations
Density functional calculations (DFT) with the gradient corrected
BLYP (Becke–Lee–Yang–Parr) functional and the double zeta valence
with polarization (DZVP) basis set, as implemented in the Turbomole
software package [32], were employed in all calculations. The Grimme's
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interactions [33,34]. The conductor-like screening model (COSMO)
model with a dielectric constant of 80 was employed to account for
the water phase [35,36]. Smaller dielectric constants (εr=2, 5, 10, 15,
20, 30, 40, 50) were used to test the stability of the stacked zwitterionic
CPFX in different environments. Random stacks of head-to-tail orienta-
tions were selected from (classical) MD simulations and their structure
was optimized at the DFT level. The optimized structure was roughly
the same, regardless of small differences in the initial relative orienta-
tion. The electrostatic potential was calculated by employing the same
functional as for geometry optimizations with the TZVP basis set but
within the Gaussian 09 computational package [23].3. Results and discussion
3.1. Atomistic simulations of neutral ciproﬂoxacin
We ﬁrst examined the interaction of neutral CPFX with the PC bi-
layer. The distribution of CPFXmolecules along the axis perpendicular
to the bilayer showed that insertion into the head group region takes
place within a few tens of nanoseconds (Fig. 2a).
In the beginning, some molecules entered symmetrically the two
sides of the bilayer as shown by the relatively symmetric distribution
obtained in the beginning of the simulation (Fig. 2a). However, at
long times a clear accumulation of the remaining CPFX on one side
of the bilayer was observed, as is highlighted by a more asymmetric
distribution (Fig. 2b). The molecules in the bilayer positioned them-
selves in the head group region at approximately 1.5 nm from the
membrane center, right under the lipid head groups. Another local
maximum in the CPFX distribution is observed in the water phase
right above the water–membrane interface at about 3 nm from the
membrane center. The free energy barrier between these two local
peaks is small given the fact that CPFX molecules readily diffused
through the head group region within the given simulation time.
However, the situation is very different in the membrane hydropho-
bic region. Considering that the density of CPFX in the membrane
center is marginal, there is reason to assume that there is a consider-
able free energy barrier in the middle of the membrane. We will come
back to this topic below (see Fig. 5).
Snapshots in Fig. 3, taken after ~200 ns ofMD simulation, agreewith
our interpretation of the density distribution data, showing several
CPFX molecules in the polar head group region, close to the hydropho-
bic chains of PCs. Most interestingly, there is a stacked aggregate of
CPFX approaching the bilayer (Fig. 3a), which explains the accumula-
tion seen in the density distribution in Fig. 2b. Hydrogen bonds with
the lipid head groups appeared to facilitate the adsorption of the CPFX
stack onto the water–bilayer interfaces. The hydrogen bonds occurreda b
Fig. 2. Distribution along the axis perpendicular to the bilayer (coordinate z) of CPFX
molecules (full line) and phosphorus atoms of the lipid headgroups (dotted line).
The ﬁrst 30 ns of the simulation are depicted in plot (a), while plot (b) shows the dis-
tribution over the entire simulation (300 ns). Membrane center is at z=0.in the beginning of the adsorption processmainly between the nitrogen
atoms of the 7-piperazine side chain and the oxygen atoms in the phos-
phate moiety of the lipid head group. At longer times, as the stack of
CPFX molecules started to enter the membrane (Fig. 3b), a signiﬁcant
number of hydrogen bonds were formed between the carboxylic
group of CPFX and the ester groups of PC. None of the other hetero-
atoms of CPFX, such as, e.g., ﬂuorine or carbonyl oxygen, appeared to
participate in the hydrogen bond formation. The pattern of these hydro-
gen bonds points to the role of piperazine in initiating the translocation
process. Indeed, the development of pipemidic acid with the addition of
a 7-piperazine side chain in the late 1960s allowed better penetration of
the bacterial cell wall, conferring improved activity against Pseudomonas
aeruginosa as well as some Gram-positive bacteria [37–40]. Nowadays,
themajority of the FQ familymembers contain piperazine or substituted
piperazine, which has been shown to enhance both permeability and
potency.
Moving on, as the stack of neutral CPFX molecules moved deeper,
crossing the ester bond region of a lipid bilayer, the stack ruptured
(Fig. 3c). During the ﬁnal stage of the simulation, neutral CPFX mole-
cules were observed to remain in the membrane hydrophobic region
as monomers. It is noteworthy that we did not identify actual translo-
cation events where a neutral CPFX molecule would have crossed the
membrane center by moving from one leaﬂet to the other. Consider-
ing the density distributions in Fig. 2, this is not surprising, since the
density of CPFX in the membrane center was observed to be marginal.
Let us ﬁnally come back to the stack formation process. Clearly,
neutral ciproﬂoxacin molecules in the water phase exhibited a pro-
nounced tendency to associate in stacks. It is in fact in the form of co-
lumnar stacks that the molecules interacted in the MD simulations
with the lipid bilayer and started to enter the head group region as
demonstrated by Fig. 3. Experimentally stacking of CPFX has been ob-
served in the interior of liposomes, where the molecules have been
found to self-associate without precipitating even at concentrations
that exceed the solubility in aqueous solutions [11]. Stacking appears
to be an intrinsic property of FQs occurring due to π–π interactions
and hydrogen bonding, as revealed by X-ray diffraction studies [41]
and spectroscopic measurements [42]. Further, our MD simulations
performed with only CPFX in water revealed that stack formation is
both a dynamic and a concentration dependent process. The CPFX
molecules associated in stacks which both formed and broke apart
over the entire length of the simulation, and whose size increased
when the concentration was changed from 0.04 M to 0.08 M.
3.2. Atomistic simulations of zwitterionic ciproﬂoxacin
Next, we considered the zwitterionic form of CPFX. Fig. 4a pre-
sents a snapshot taken from the end of the simulation, showing ag-
gregates of two or more zwitterions in the water phase. While
neutral CPFX entered and stayed in the lipid bilayer, zwitterionic
CPFX only formed aggregates, which remained in the water phase.
Very few molecules approached the lipid head groups during the
300 ns simulation time as evidenced by the density distribution in
Fig. 4b. Presumably the large charges on carboxyl and piperazine,
the substituents shown to be mainly involved in the interaction of
the drug with the lipid bilayer, prevent zwitterions from entering
the bilayer.
Fig. 4b clearly shows that the number density of zwitterionic CPFX
in the membrane hydrophobic region is vanishingly small, and is con-
siderably smaller compared to the neutral case. The free energy barri-
er associated with translocation of zwitterionic CPFX monomers is
therefore expected to be substantially larger compared to the barrier
for neutral CPFX monomers.
As in the case of neutral CPFX, also for zwitterionic molecules stac-
king takes place independently of the bilayer and depends on the
CPFX concentration. At concentrations of 0.04 M we observed forma-
tion of only small two-molecule stacks. At higher concentration
Fig. 3. Snapshots of MD simulation showing a stack of neutral CPFX (a) approaching
and (b) entering the lipid bilayer. (c) Subsequent rupture of CPFX stacks during the
early stages of bilayer penetration, showing that only individual CPFX molecules even-
tually translocate through the membrane. CPFX molecules are shown in red. Light blue
chains represent the hydrophobic region of the bilayer and nitrogen (pink) and phos-
phorous (green) atoms represent the hydrophilic region. Water molecules as well as
PC hydrogens have been omitted for clarity.
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perimental observations that have been reported on the stacking of
FQs [11,42,43], no atomistic level evidence has been available for
this process. However, self-aggregation of drugs was often proven
to play a functional role in their activity [43,44] and the same idea
can be speculated to hold true also in the case of FQ stacking. Indeed,
if we consider a simpliﬁed model where zwitterionic CPFX molecules
are electric dipoles, it is clear that by their antiparallel association the
electric ﬁeld produced by each dipole would compensate for the ﬁeld
produced by the other. This would result in a reduction of the net
electric ﬁeld measured externally, thus reducing the electrostatic po-
tential of the CPFX complex and favoring their penetration into the
less polar environment of the lipid bilayer. A similar effect was pres-
ented for the halothane anesthetic in which case partial cancelation of
molecular dipole moments through stacking determined the localiza-
tion of a two molecules stack in the hydrophobic region of the target
protein [44]. Additionally, the authors of ref. [44] identiﬁed pairing of
the halothane molecules by electrostatic interaction to be a potential
cause of the annihilation of the anesthetic action of the drug.3.3. Free energy roﬁles
The free energy proﬁles of monomeric CPFX, zwitterionic and
neutral, are shown in Fig. 5. In both cases the excess free energy
rises slightly as CPFX enters the head group region amounting to
3.8 kJ/mol (about 1.5 kBT) for the neutral case and almost twice
this value (6.5 kJ/mol, corresponding to 2.6 kBT) for the zwitterionic
one. As CPFX moves deeper into the bilayer, the free energy de-
creases and the global minimum is reached within the leaﬂet in the
high-density region of the acyl chains. Double bonds of unsaturated
lipids are typically localized in this region. The zwitterionic form ex-
hibits a minimum, which is slightly closer to the head group region
than in the neutral case. However, the drop in free energy is modest
for zwitterionic CPFX, resulting in a positive excess free energy when
located in the center of the bilayer, suggesting a strong incompatibil-
ity with this region. Instead, free energy calculations conﬁrm that
zwitterionic CPFX prefers being in the water phase. On the contrary,
the value of −14 kJ/mol (−6 kBT) obtained for neutral CPFX clearly
indicates, in agreement with equilibrium MD simulations, that neu-
tral CPFX can penetrate into the lipid bilayer and that the process is
energetically favorable.
Deeper in the bilayer, close to its center, the free energy for the
neutral drug form rises, still remaining below 8 kJ/mol (3.2 kBT). As
the free energy barrier is comparable to thermal energy, neutral
CPFX is able to translocate through the membrane in reasonable
time scales. Full translocation events were not observed in the pre-
sent MD simulations, but as Fig. 2b highlights, the neutral form of
CPFX spends quite extensive periods of time in the vicinity of the
membrane center, suggesting that translocations would be observed
over time scales of the order of microseconds or larger.
The barrier for zwitterionic CPFX is almost one order of magnitude
higher (72.7 kJ/mol, about 29 kBT) compared to the neutral case, and
translocation of these molecules is expected to be at most a rare
event. The height of the barrier for zwitterionic CPFX was further con-
ﬁrmed with a short umbrella sampling simulation, which yielded
similar results.
Fig. 4. (a) Selected snapshot taken at the end of a 300 ns MD simulation revealing zwitterionic CPFX in the water phase aggregated in stacks. (b) Density distribution of zwitterionic
CPFX (full line) and phosphorous atoms in lipids (dotted line). Membrane center is at z=0.
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The free energy simulations allow us to investigate several charac-
teristics of CPFX at different depths in the membrane. Fig. 6 reveals
that the molecules rotate freely in the water phase, while inside the bi-
layer there are some clear tendencies. The zwitterionic molecule tends
to align perpendicular to the membrane normal to compensate for its
charges. This holds inside the bilayer down to about 0.4 nm from the
membrane center, where zwitterionic CPFX suddenly changes its orien-
tation, aligning itself to be in parallel to the membrane normal. We dis-
cuss this behavior below in more detail. Meanwhile, the neutral drug
aligns mostly parallel to the membrane normal, maximizing its hydro-
phobic interactions with the acyl chains.
The lateral diffusion coefﬁcient of the drug inside the membrane
can be calculated from the free energy simulations despite the con-
straint with respect to the z axis. Both degrees of freedom along the
x and y axes in the membrane plane are retained, and thus the lateral
diffusion coefﬁcient can be calculated from the mean squared dis-
placement (MSD) of the atoms in the xy plane as a function of time.
In each case, a trajectory over 7.5 ns, representing the second half of
each simulation was used in the calculation and the ﬁt was performed
to the MSD data starting from 50 ps to 1 ns. The obtained resultsFig. 5. Excess free energy of both zwitterionic (dashed line) and neutral (full line)
CPFX molecules as a function of distance from the center of the bilayer. The curves
are mirrored to show the values in the whole bilayer system. Error limits are drawn
as gray areas. Key values of the curves are explicitly listed in the ﬁgure. Membrane
center is at z=0.indicate that both forms of CPFX exhibit quite fast lateral diffusion in-
side the membrane. We ﬁnd diffusion coefﬁcients to be in the order of
10−6 cm2/s (see Fig. 7), which is one order of magnitude larger than
the lateral diffusion of lipids in ﬂuid-phase (cholesterol-poor) mem-
branes. Also, our results indicate that in the core region of the bilayer,
neutral CPFX moves faster than zwitterionic one, promoting its
chances for permeation through the free energy barrier in the center
of the membrane. As longer free energy simulations would be appro-
priate for a quantitative estimation of lateral diffusion coefﬁcients, we
have validated our results by comparing the lateral diffusion coefﬁ-
cients of lipids with the ones obtained from free energy calculations.
A simulation over 140 ns was found to yield a lipid lateral diffusion
coefﬁcient of 1.05×10−7 cm2/s, which, considering the large size
of a lipid molecule, compares reasonably well with the value of
1.54×10−7 cm2/s obtained from free energy calculations. The lipid
diffusion coefﬁcient we found is also in very good agreement with
experimental values that range around 1×10−7 cm2/s [45,46] for
numerous phospholipids close to physiological temperature. When
free energy estimates for lateral diffusion are considered for mole-
cules that are smaller than lipids, one expects smaller deviations,
highlighting that the main qualitative conclusions outlined above
for CPFX are therefore valid.Fig. 6. Angle between the vector from the carbon of the carboxylic group to the nitro-
gen of the secondary amine group and the z axis at different constraint depths. Data for
the zwitterionic and neutral forms of CPFX are drawn in dashed and continuous lines,
respectively. Standard deviation is shown as gray areas around the curves. Membrane
center is at z=0.
Fig. 7. Lateral diffusion coefﬁcients of zwitterionic (left) and neutral (right) CPFX inside
the membrane (its center being at z=0), the data for lateral diffusion being shown here
for varying distances from the membrane center. The solid line is to guide the eye, rep-
resenting the running average of lateral diffusion coefﬁcient values marked with “x”. In
the same manner, the shaded area represents the running average of the error limits.
These limits are obtained for individual z values as a difference of the two diffusion coef-
ﬁcient values obtained from ﬁts to the two halves of the total ﬁtting interval.
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havior. It can be seen from Fig. 8 that neutral CPFX loses hydrogen-
bonded water molecules as it permeates into the bilayer. Essentially,
the number of hydrogen bonds becomes zero in the center of the
membrane. This is however not the case for the zwitterionic form of
the molecule (see Fig. 8) which retains several water molecules (~7
hydrogen bonds with water) even in the very hydrophobic center of
the membrane. Consequently, zwitterionic CPFX appears to remain
connected to the water phase from both interfaces of the bilayer,
which obviously hinders its diffusive motion.
Hydrogen bonding between CPFX and lipid molecules appears to
be small and there is no substantial difference between the neutral
and zwitterionic forms. Nevertheless, one can see from Fig. 8 that hy-
drogen bonding of neutral CPFX with the lipids increases in the
headgroup region and can contribute, as discussed in Section 3.1, to
the penetration of the molecules into the membrane.
A closer look at the hydrogen bonding pattern of zwitterionic
CPFX offers additional insight into the high translocation barrier
(Fig. 5) experienced by this form of the molecule. In Fig. 9 we present
snapshots of both zwitterionic and neutral CPFX molecules together
with water molecules. The pictures describe situations where the
drug molecules are either in the center of the bilayer or 0.4 nm
from the center. As can be seen, the behavior is very different be-
tween the two cases. Closer to the interface (z=0.4 nm) both CPFX
forms are bound to water molecules but exhibit a different orienta-
tion which, in the case of the zwitterionic form (oriented perpendic-
ular to membrane normal, Fig. 9c), facilitates formation of hydrogenFig. 8. Number of hydrogen bonds of CPFX in water and lipid phases: neutral CPFX with
membrane (solid line); zwitterionic CPFX with membrane (dotted line); neutral CPFX
with water (dashed line); zwitterionic CPFX with water (dash–dot line).bonds with both polar ends of the molecules. At the same time, neu-
tral CPFX stands upright along the membrane normal (Fig. 9a).
When the drug molecules are pulled to the center of the bilayer
(z=0), their behavior is drastically different. While neutral CPFX is
completely depleted of water molecules (Fig. 9b), zwitterionic CPFX
reorients from being parallel to the membrane plane to a position
where it is parallel to the membrane normal (Fig. 9d), and by doing so
it forms water-strings to both water–membrane interfaces of the bilay-
er. As the sudden reorientation takes place (z changing from 0.4 to
0.0 nm), about half of the hydrogen bonds with water are broken and
then reformed on the other side of the bilayer (Fig. 9d). Considering
that in the center of the membrane zwitterionic CPFX has ~7 hydrogen
bonds with water, with about half of them at each end, one can make a
crude estimate of the translocation barrier as 3.5 times the energy of a
hydrogen bond.With the formation of a single hydrogen bond being ac-
companied by the release of 12–24 kJ/mol of enthalpy [47], we obtain
an energy barrier of about 42–84 kJ/mol that is in the same ballpark as
the computed one (72.7 kJ/mol). This comparison is not conclusive
since the enthalpic value does not include a contribution due to changes
in entropy, but it yet highlights that the major translocation barrier of
zwitterionic CPFX is largely due to the formation of water defects con-
necting CPFX to bulkwater on both sides of the lipidmembrane. Related
ﬁndings have been found for lipid ﬂip-ﬂops and translocation of
charged and polar amino acids [48,49].
3.5. Quantum mechanical studies for CPFX monomers and complexes
In order to get a better understanding of the importance of stack
formation on the interaction of CPFX with lipid membranes, we
employed DFT to calculate the electrostatic potential of CPFX in a di-
electric continuum. Calculations were performed on both neutral and
zwitterionic monomers as well as on stacks of two or three zwitter-
ionic CPFX molecules. The mapping of the potential on the van der
Waals surface is shown in Fig. 10.
Considering ﬁrst CPFX monomers, we found a high accumulation
of charge on the zwitterionic CPFX in water as compared to the neu-
tral form. The extreme values of the potential are almost tripled for
the zwitterionic case compared to the neutral one, and they are local-
ized mainly on the carboxyl and piperazine substituents (the two
polar ends of the CPFX molecule). Thus, our observation that zwitter-
ionic CPFX does not readily approach the bilayer is not surprising
given its large localized charges, which make it appear basically as a
dipole. However, stacking of zwitterionic CPFX molecules in the ob-
served anti-parallel arrangement changes the picture considerably.
Stacking lowers the electrostatic potential signiﬁcantly (Fig. 10) in
the case of the dimer. Despite still high extreme values on piperazine,
the overall potential of the group appears signiﬁcantly reduced. In
Fig. 10 this is visualized as large green areas which correspond to
values of ~1 V. Also the electrostatic potential on the carboxyl substit-
uents is reduced, with the highest values lowered by 30%. The reduc-
tion of the electrostatic potential is even more pronounced for the
sandwiched molecule in the trimer stack, where the potential is de-
creased by almost one order of magnitude as compared to an isolated
individual zwitterionic CPFX. At the same time the extreme values in
the trimer are also lowered by almost 30% on both polar ends of the
molecules. Not surprisingly, also stacking in vacuum turned out to
have basically the same effect on the electrostatic potential despite
some differences in the absolute values.
The above QM analysis brings about the reduction of the electro-
static potential during stack formation, thus highlighting that the
role of stacking is likely very important in translocation of FQs
through lipid bilayers. However, once zwitterionic stacks approach
the bilayer and start to enter it, they begin to lose the beneﬁcial effect
of solvation, which is known to contribute greatly to the stability of
zwitterions. Given this, are zwitterionic stacks stable in the mem-
brane environment?
Fig. 9. Snapshots of neutral (a, b) and zwitterionic (c, d) CPFX and water molecules taken in the center of the membrane (b, d) and at a distance of 0.4 nm from the center (a, c). For
clarity, lipids are not shown.
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on zwitterionic dimers in the gas phase and also in implicit solvents
with different permittivity. We found that zwitterionic dimers
appeared to be not very stable in the gas phase. A simple geometry
optimization of two stacked CPFX molecules in vacuum yielded
two neutral dipolar molecules, due to intermolecular transfer of
protons. In a dielectric continuum, proton transfer was observed
upon geometry optimization with dielectric constants up to ~15,
but not beyond ~20. That is, stacks of zwitterionic CPFX are stable
only in polar environments, with dielectric constants of ε~20 and
larger. This implies that stacks are not stable in the membrane inte-
rior nor in the lipid head group region having dielectric constants of
ε~2–4 and ε~12–18, respectively [50,51]. Instead, they are expected
to be stable in the water phase.
To consider this further, we performed DFT calculations in the
presence of a few explicit water molecules. Intermolecular proton
transfer was prevented if a large enough number of water molecules
were added to the system. CPFX dimer stacks surrounded by a shell of
1.7 Å of water molecules (approximately 4–5 molecules located
around carboxylic groups) still underwent intermolecular proton
transfer. When we included water within a distance of 2 Å (about
15 molecules out of which 4 around piperazine and one around car-
boxyl), stabilization of the zwitterions was achieved. The number of
water molecules coincides with the one shown by the DFT studies
of Lambert et al. to stabilize levoﬂoxacin [52]. According to our anal-
ysis of CPFX–water hydrogen bonding, even a single zwitterionicCPFX would not be stabilized by water molecules since ~3.5 hydrogen
bonds are observed at each of its polar ends. Summarizing, the proton
transfer observed in our QM calculations appears to be a highly prob-
able process as CPFX stacks cross the water–membrane interface and
penetrate the membrane.
4. Conclusions
Concluding, our data provide compelling evidence that only the
neutral form readily permeates through a lipid bilayer. The transloca-
tion process starts from the water phase where CPFX molecules ap-
pear as stacks. Close to a membrane they form hydrogen bonds
with the lipid head groups. The pattern of these hydrogen bonds
points to the role of piperazine in initiating the translocation process,
which explains the enhanced permeability of piperazin substituted
FQs observed in experiments [37–40]. Zwitterionic CPFX molecules
partition mainly to the water phase due to their strongly polar nature.
However, charge distribution arising from their interaction and sub-
sequent stack formation signiﬁcantly reduces the polarity of the
stacks potentially favoring their insertion into the bilayer. This
would presumably reduce the difference in the energetic barrier
upon entering the bilayer, which was revealed by free energy calcula-
tions to be almost twice as large for a single zwitterionic CPFX mole-
cule as compared to a neutral one.
To move on, ciproﬂoxacin molecules diffuse through a lipid mem-
brane in their neutral form, neutralization taking place due to
Fig. 10. Electrostatic potential maps at the molecular van der Waals surface in a dielec-
tric continuum corresponding to the water phase (dielectric constant 80). Starting
structures for DFT optimization were taken from classical all-atom simulations. Elec-
trostatic potential values are given in units of Volt.
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lvation of neutral and zwitterionic forms, respectively. In the absence
of this process, the translocation barrier of zwitterionic CPFX is very
high, rendering the translocation of zwitterionic CPFX a rare event.
For the neutral molecule, however, translocation can be expected to
be quite frequent given that the free energy barrier for translocation
is 3.2 kBT and therefore comparable to thermal energy. The large
free energy barrier experienced by zwitterionic CPFX close to the cen-
ter of the membrane can largely be explained by the formation of
water defects on both sides of the membrane and the accompanied
breaking of hydrogen bonds as CPFX undergoes motion through the
membrane core region. While other factors like chelation with diva-
lent ions or trans-membrane pH gradient have been shown to con-
tribute to the passive diffusion of FQs through the membrane too[53], the proposed mechanism can be considered as the dominant
one as it explains also experiments that involve model lipid bilayers
and FQs alone.
We have provided here an in-depth picture for the interaction of
lipid bilayers with a major FQ, ciproﬂoxacin. We have elucidated one
of the fundamental issues regarding the diffusion mechanism of such
drugs through cellular membranes. Important to stress here is that the
present results go beyond the class of FQs alone, as the suggestedmech-
anism can largely contribute to the diffusion of many other ampholitic
drugs with stacking tendencies. With ampholytes being a rule rather
than an exception in biochemistry, and with the large diversity of
ampholytic drugs on the market, the importance of understanding the
interaction of such compounds with cellular membranes cannot be
overestimated. The rationalization of the mechanism of interaction
and translocation of ampholytes outlined here is expected to contribute
to biochemistry and medicinal chemistry in particular, when more po-
tent drugs are being developed.
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